Maria-Lucia Angelotti (Maria Lucia Angelotti)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Diabetic Nephropathy

Hematopoietic Stem Cell

Small Cell Lung Cancer

Top Venues

Journal of personalized medicine

Journal of the American Society of Nephrology : JASN

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhihui Zhu, Karoline At Rosenkranz, Yoshihiro Kusunoki, Chenyu Li, Martin Klaus, Oliver Gross, Maria-Lucia Angelotti, Giulia Antonelli, Luigi Cirillo, Paola Romagnani, Nassim Bouteldja, Alireza Vafaei Sadr, Roman David Bülow, Peter Boor, Hans-Johachim Anders
Finerenone Added to RAS/SGLT2 Blockade for Chronic Kidney Disease in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice. Journal of the American Society of Nephrology : JASN (2023)
Maria Elena Melica, Giulia Antonelli, Roberto Semeraro, Maria-Lucia Angelotti, Gianmarco Lugli, Samuela Landini, Fiammetta Ravaglia, Gilda La Regina, Carolina Conte, Letizia De Chiara, Anna Julie Peired, Benedetta Mazzinghi, Marta Donati, Alice Molli, Stefanie Steiger, Alberto Magi, Bartalucci Niccolò, Valentina Raglianti, Francesco Guzzi, Laura Maggi, Francesco Annunziato, Alexa Burger, Elena Lazzeri, Hans-Johachim Anders, Laura Lasagni, Paola Romagnani
Differentiation of crescent-forming kidney progenitor cells into podocytes attenuates severe glomerulonephritis in mice. Science translational medicine 14 (657) (2022)
Giulia Cantini, Laura Fei, Letizia Canu, Elena Lazzeri, Mariangela Sottili, Michela Francalanci, Maria-Lucia Angelotti, Giuseppina De Filpo, Tonino Ercolino, Stefania Gelmini, Monica Mangoni, Gabriella Nesi, Constanze Hantel, Massimo Mannelli, Mario Maggi, Michaela Luconi
Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. Journal of personalized medicine 11 (11) (2021)